Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;71(7):2911-2912.
doi: 10.4103/IJO.IJO_872_23.

Insulin eye drops for neurotrophic keratitis

Mayur R Moreker  1 , Nikhil Thakre  1 , Abhinav Gogoi  1 , Ronak P Bhandari  2 , Rashmikant C Patel  1
Affiliations

Insulin eye drops for neurotrophic keratitis

Mayur R Moreker et al. Indian J Ophthalmol. 2023 Jul.
No abstract available

Keywords: Corneal Ulcer; Insulin eye drops; Neurotrophic Keratitis.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
(a) Right eye of a 55-year-old gentleman with Grade IV neurotrophic keratitis. (b) Right eye of a 55-year-old gentleman with Grade IV neurotrophic keratitis, 12 days after use of insulin eye drops. (c) Right eye of a 55-year-old gentleman with Grade IV neurotrophic keratitis, 25 days after use of Insulin eye drops
Figure 2
Figure 2
(a) Right eye of a 41-year-old gentleman, diabetic patient, with post-COVID mucormycosis at presentation. (b) Right eye of a 41-year-old gentleman, diabetic patient, with post-COVID mucormycosis that developed NK despite an initial temporary tarsorrhaphy with intense lubrication. (c) Right eye of a 41-year-old gentleman, diabetic patient, with post-COVID mucormycosis with partial resolution after a permanent tarsorrhaphy and amniotic membrane transplantation. (d) Right eye of a 41-year-old gentleman, diabetic patient, with post-COVID mucormycosis with the resolution of congestion and a stable ocular surface, after the introduction of insulin eye drops
See this image and copyright information in PMC

References

    1. Wang AL, Weinlander E, Metcalf BM, Barney NP, Gamm DM, Nehls SM, et al. Use of topical insulin to treat refractory neurotrophic corneal ulcers. Cornea. 2017;36:1426–8. - PMC - PubMed
    1. Galvis V, Niño CA, Tello A, Grice JM, Gomez MA. Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma. Arch Soc Esp Oftalmol. 2019;94:100–4. - PubMed
    1. Bastion ML, Ling KP. Topical insulin for healing of diabetic epithelial defects: A retrospective review of corneal debridement during vitreoretinal surgery in Malaysian patients. Med J Malaysia. 2013;68:208–16. - PubMed
    1. Rocha EM, Cunha DA, Carneiro EM, Boschero AC, Saad MJ, Velloso LA. Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface. Invest Ophthalmol Vis Sci. 2002;43:963–7. - PubMed
    1. Bartlett JD, Turner-Henson A, Atchison JA, Woolley TW, Pillion DJ. Insulin administration to the eyes of normoglycemic human volunteers. J Ocul Pharmacol. 1994;10:683–90. - PubMed